Kavalactones, A Novel Class of Protein Glycation and Lipid Peroxidation Inhibitors

Abstract

Both advanced glycation endproducts and advanced lipoxidation endproducts are implicated in many age-related chronic diseases and in protein ageing. In this study, kawain, methysticin, and dihydromethysticin, all belonging to the group of kavalactones, were identified as advanced glycation endproduct inhibitors. With IC₅₀ values of 43.5 ± 1.2 µM and 45.0 ± 1.3 µM for kawain and methysticin, respectively, the compounds inhibited the in vitro protein glycation significantly better than aminoguanidine (IC₅₀ = 231.0 ± 11.5 µM; p = 0.01), an established reference compound. Kawain and methysticin also inhibited the formation of dicarbonyl compounds, which are intermediates in the process of advanced glycation endproduct formation. Similarly, kawain and aminoguanidine prevented the formation of thiobarbituric reactive substances in both low-density lipoprotein and linoleic acid oxidation. Moreover, kawain and aminoguanidine prevented advanced glycation endproduct formation by chelating Fe³⁺ and Cu²⁺ two to three times better than aminoguanidine. Furthermore, kawain increased the mean life span of Caenorhabditis elegans exposed to high glucose. With glycation inhibiting, lipid peroxidation inhibiting, metal chelating properties, and life span extending ability, kavalactones show a high potential as advanced glycation endproducts and advanced lipoxidation endproduct inhibitors.

Key words

advanced glycation endproducts (AGEs) - advanced lipoxidation endproducts (ALEs) kavalactones - kawain - chelation - Caenorhabditis elegans

• References

• 1 Schmidt AM, Hori O, Brett J, Yan SD, Wautier JL, Stern D. Cellular receptors for advanced glycation endproducts. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler Thromb 1994; 14: 1521-1528
• 2 Munch G, Thome J, Foley P, Schinze R, Riederer P. Advanced glycation endproducts in ageing and Alzheimerʼs disease. Brain Res Rev 1997; 23: 134-143
• 3 Baynes JW. Pyridoxamie, a versatile inhibitor of advanced glycation and lipoxidation reactions. Int Congr Ser 2002; 1245: 31-35
• 4 Basta G, Schmidt AM, Caterina RD. Avanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc Res 2004; 63: 582-592
• 5 Heijst JWJV, Niessen HWM, Hoekman K, Schalkwijk CG. Advanced glycation end products in human cancer tissues. Ann N Y Acad Sci 2006; 1043: 725-733
• 6 Negre-Salvayre A, Auge N, Ayala V, Basaga H, Boada J, Brenke R, Chapple S, Cohen G, Feher J, Grune T, Lengyel G, Mann GE, Pamplona R, Poli G, Portero-Otin M, Riahi Y, Salvayre R, Sasson S, Serrano J, Shamni O, Siems W, Siow RCM, Wiswedel I, Zarkovic K, Zarkovic N. Pathological aspects of lipid peroxidation. Free Radic Res 2010; 44: 1125-1171
• 7 Boerner RJ, Sommer H, Berger W, Kuhn U, Schmidt U, Mannel M. Kava-kava extract LI 150 is as effective as opipramol and buspirone in generalised anxiety disorder – an 8-week randomized, double-blind multi-centre clinical trial in 129 out-patients. Phytomedicine 2003; 10 Suppl. 4: 38-49
• 8 Upadhyay A, Chompoo J, Kishimoto W, Makise T, Tawata S. HIV-1 integrase and neuraminidase inhibitors from Alpinia zerumbet . J Agric Food Chem 2011; 59: 2857-2862
• 9 Xuan TD, Fukuta M, Wei AC, Elzaawely AA, Khanh TD, Tawata S. Efficacy of extracting solvents to chemical components of kava (Piper methysticum) roots. J Nat Med 2008; 62: 188-194
• 10 Chompoo J, Upadhyay A, Kishimoto W, Makise T, Tawata S. Advanced glycation end products inhibitors from Alpinia zerumbet rhizomes. Food Chem 2011; 129: 709-715
• 11 Hidalgo FJ, Zamora R. Interplay between the maillard reaction and lipid peroxidation in biochemical systems. Ann N Y Acad Sci 2005; 1043: 319-326
• 12 Rahbar S. Novel inhibitors of glycation and AGE formation. Cell Biochem Biophys 2007; 48: 147-157
• 13 Harris CS, Beaulieu LP, Fraser MH, McIntyre KL, Owen PL, Martineau LC, Cuerrier A, Johns T, Haddad PS, Bennett AL, Arnason JT. Inhibition of advanced glycation end product formation by medicinal plant extracts correlated with phenolic metabolites and antioxidant activity. Planta Med 2011; 77: 196-204
• 14 Pashikanti S, De Alba DR, Boissonneault GA, Cervantes-Laurean D. Rutin metabolites: novel inhibitors of nonoxidative advanced glycation end products. Free Rad Biol Med 2010; 48: 656-663
• 15 Morel S, Helesbeux JJ, Séraphin D, Derbré S, Gatto J, Aumond MC, Abatuci Y, Grellier P, Beniddir MA, Le Pape P, Pagniez F, Litaudon M, Landreau A, Richomme P. Anti-AGEs and antiparasitic activity of an original prenylated isoflavonoid and flavanones isolated from Derris ferruginea . Phytochemistry Lett 2013; 6: 498-503
• 16 Rahbar S, Natarajan R, Yerneni KK, Scott S, Gonzales N, Nadler JL. Evidence that pioglitazone, metformin and pentoxifylline are inhibitors of glycation. Clin Chim Acta 2000; 301: 65-77
• 17 Brownlee M. Biochemistry and molecular biology of diabetic complications. Nature 2001; 414: 813-820
• 18 Voziyan PA, Metz TO, Baynes JW, Hudso BG. A post-Amadori inhibitor pyridoxamine also inhibits chemical modification of proteins by scavenging carbonyl intermediates of carbohydrate and lipid degradation. J Biol Chem 2002; 277: 3397-3403
• 19 Nagai R, Murray DB, Metz TO, Baynes JW. Chelation: a fundamental mechanism of action of AGE inhibitors, AGE breakers, and other inhibitors of diabetes complications. Diabetes 2012; 61: 549-559
• 20 Price DL, Rhett PM, Thorpe SR, Baynes JW. Chelating activity of advanced glycation end-product inhibitors. J Biol Chem 2001; 276: 48967-48972
• 21 Sajithlal GB, Chithra P, Chandrakasan G. The role of metal catalysed oxidation in the formation of advanced glycation end products: an in vitro study on collagen. Free Rad Biol Med 1998; 25: 265-269
• 22 Onorato JM, Jenkins AJ, Thorpe SR, Baynes JW. Pyridoxamine, an inhibitor of advanced glycation reactions, also inhibits advanced lipoxidation reactions. J Biol Chem 2000; 275: 21177-21184
• 23 Miyata T, Ueda Y, Asahi K, Izuhara Y, Inagi R, Saito A, van Ypersele de Strihou C, Kurokawa K. Mechanism of the inhibitory effect of OPB-9195 [(±)-2-isopropylidenehydrazoneo-4-oxo-thaizolidin-5-ylactenilide] on advanced glycation endproduct and advanced lipoxidation end product formation. J Am Soc Nephrol 2000; 11: 1719-1725
• 24 Schlotterer A, Kukudov G, Bozorgmehr F, Hutter H, Du X, Oikonomou D, Ibrahim Y, Pfisterer F, Rabbani N, Thornalley P, Sayed A, Fleming T, Humpert P, Schwenger V, Zeier M, Hamann A, Stern D, Brownlee M, Bierhaus A, Nawroth P. C. elegans as model for the study of high glucose-mediated life span reduction. Diabetes 2009; 58: 2450-2456
• 25 Reddy VP, Garrett MR, Perry G, Smith MA. Carnosine: a versatile antioxidant and antiglycating agent. Sci Aging Knowl Environ 2005; 2005: 12
• 26 Buettner GR. In the absence of catalytic metals ascorbate does not autoxidize at pH 7: ascorbate as a test for catalytic metals. J Biochem Biophys Methods 1988; 16: 27-40
• 27 Wallin B, Rosengren B, Shertzer HG, Camejo G. Lipoprotein oxidation and measurement of thiobarbituric acid reacting substances formation in a single microtiter plate: its use for evaluation of antioxidants. Anal Biochem 1993; 208: 10-15
• 28 Upadhyay A, Chompoo J, Taira N, Fukuta M, Tawata S. Significant longevity-extending effects of Alpinia zerumbet leaf extracts on the life span of Caenorhabditis elegans . Biosci Biotechnol Biochem 2013; 77: 217-223